PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31141523-8	2019	The results showed that the level of alpha-fetoprotein was significantly reduced in PCA-ZnAl (350+-43.90 ng/mL), doxorubicin (DOX) (290+-20.52 ng/mL) and ZnAl-LDH (390+-19.65 ng/mL) treated animals compared to HCC mice treated with normal saline (580.4+- 52.04 ng/mL).	Doxorubicin	113-124	alpha fetoprotein	Mus musculus	37-54	
31141523-8	2019	The results showed that the level of alpha-fetoprotein was significantly reduced in PCA-ZnAl (350+-43.90 ng/mL), doxorubicin (DOX) (290+-20.52 ng/mL) and ZnAl-LDH (390+-19.65 ng/mL) treated animals compared to HCC mice treated with normal saline (580.4+- 52.04 ng/mL).	Doxorubicin	126-129	alpha fetoprotein	Mus musculus	37-54